Supporting female founder initiatives across the UK & Ireland

Find out more  
← Back to portfolio Porfolio / PhoreMost

PhoreMost

A biopharmaceutical company

Company overview

PhoreMost’s SITESEEKER® platform enables the inception of First-in-class drug discovery programmes. Using this unique approach, PhoreMost is developing an internal asset pipeline in oncology and other diseases of ageing.

Additionally, PhoreMost is engaged in SITESEEKER collaborations with Pharma and Biotech across multiple therapeutic areas.

Website
PhoreMost

Company information

Head office
  • Cambridgeshire
CEO
  • Neil Torbett
Chair
  • Chris Torrance
BGF office
BGF team
Investment date
  • Mar 2021
Total BGF investment
  • £8.5m